Delivery Order SPE2DB20D3103-SPE2DB21FP8N4
Award Date
8/11/21
Potential Completion Date
8/12/21
Potential Value
$3.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of pharmaceutical products, specifically the medication Multihance 529 mg/ml vial 10ml, to the Defense Logistics Agency (DLA) for a total ceiling value of $3,054.00. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop...
This federal contract award is for the delivery of MULTIHANCE 529 MG/ML VIAL 20ML to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. The $11,466.00 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has an ultimate completion date of August 20, 2024, is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held...
This contract award, valued at $3,091.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of MULTIHANCE 529 MG/ML VIAL 10ML. The contract is a delivery order, with a firm fixed price pricing type and an ultimate completion date of June 23, 2022. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which is the parent company. Cencora, Inc. holds a...
This federal contract award, with an ID of SPE2DB20D3103|SPE2DB22FN9D3, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MULTIHANCE 529 MG/ML VIAL 20ML, a medical product, with an ultimate completion date of June 15, 2022 and a ceiling value of $5,989.50. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by...
This contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of the pharmaceutical product MULTIHANCE 529 MG/ML VIAL 20ML. The contract has a firm fixed-price ceiling value of $1,959.88 and a completion date of January 16, 2025. The contract is a Delivery Order and does not utilize any set-aside designations. AmerisourceBergen Drug Corp is the prime contractor, and this award is associated with a larger Indefinite Delivery Contract (IDC) the...
This federal contract award, valued at $2,470.36, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of MULTIHANCE 529MG/ML 5S, a medical product. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a vehicle for providing a comprehensive range of...
This federal contract award is for the delivery of MULTIHANCE 529 MG/ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,298.40 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also a significant federal contractor. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This contract award, valued at $14,515.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...
The Defense Logistics Agency awarded a $10,613.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 529 milligrams per milliliter vials of MultiHance contrast agent. The contract calls for 20 milliliter vials of the product to be delivered to a facility in Conshohocken, Pennsylvania by July 25, 2023. As a major supplier of pharmaceuticals and medical supplies to the U.S. Department of Defense, this order for contrast media is consistent with the Defense...
This federal contract award, valued at $7,419.62, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...